Aqasim: The Sidal complex will start manufacturing insulin, starting from the first quarter of 2023 – Al-Hiwar Al-Jazairia

The President and Director General of the Saidal complex, Fattoum Agasem, announced today, Tuesday, that the complex has begun “manufacturing insulin, starting from the first trimester of the year 2023.”

In remarks broadcast on the national radio, Agasim said that the insulin production process in Algeria will be in the production unit “Sidal Constantine”, at a rate of 1 million packages annually.

Speaking about the presence of SAIDAL in the global market, the President of the Directorate General of the ASEAN recorded that “SAIDAL operates according to a well-defined strategy to be present in Africa, in implementation of the instructions of the President of the Republic, Mr. The African market is the most developed, compared to other markets.”